Company
Company

Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.

Always stay updated with the free CMN Newsletter.

KSQ Therapeutics

Company Type: Therapeutic development

Main focus: Discovering optimal gene targets for drug development

Company stage: Clinical

Diseases: Cancer and autoimmune disease

Genome-editing tool: CRISPR-Cas9

Funding stage: Series C

Location: Lexington, Massachusetts, USA

Website: https://ksqtx.com/#home

Pipeline: https://ksqtx.com/#pipeline

Partners:

KSQ Therapeutics is a clinical-stage company that combines its CRISPRomics® discovery platform and CRISPR technologies to decode the genome and identify optimal gene targets for drug development. KSQ Therapeutics focuses on oncology treatments and drug discovery for autoimmune disease including targeted oncology, cell therapy, and immuno-regulation therapies. KSQ Therapeutics' pipeline currently contains seven therapeutics in development.

Tags

HashtagKSQ Therapeutics

Company: KSQ Therapeutics
close
Search CRISPR Medicine